Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
about
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
description
clinical trial
@en
klinisch onderzoek
@nl
name
Osimertinib in Treating Partic ...... ell Lung Cancer Before Surgery
@en
type
label
Osimertinib in Treating Partic ...... ell Lung Cancer Before Surgery
@en
prefLabel
Osimertinib in Treating Partic ...... ell Lung Cancer Before Surgery
@en
P1476
A Phase II Study to Evaluate N ...... ant Non-Small Cell Lung Cancer
@en
P3098
NCT03433469
P4844
P580
2018-07-31T00:00:00Z
P582
2021-05-31T00:00:00Z